Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Thoratec Corp. (THOR)

33.60 Down 0.32(0.94%) Apr 17, 4:00PM EDT
|After Hours : 33.60 0.00 (0.00%) Apr 17, 4:56PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Thoratec Corp.
6035 Stoneridge Drive
Pleasanton, CA 94588
United States - Map
Phone: 925-847-8600

Index Membership:N/A
Industry:Medical Instruments & Supplies
Full Time Employees:951

Business Summary 

Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. The company’s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure; and PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. In addition, the company provides Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising home discharge and post-cardiotomy myocardial recovery. It sells its products through direct sales force and distributors in the United States and internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Thoratec Corp.

Corporate Governance 
Thoratec Corp.’s ISS Governance QuickScore as of Apr 1, 2014 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 2; Compensation: 4.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Gerhard F. Burbach , 51
Chief Exec. Officer, Pres and Exec. Director
Mr. Taylor C. Harris , 38
Chief Financial Officer, Principal Accounting Officer and VP
Mr. David A. Lehman , 53
Sr. VP, Gen. Counsel and Sec.
Mr. Joseph G. Sharpe ,
VP of Operations
Ms. Laxmi N. Peri ,
VP of Product Devel. & Technology
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders